REKLAMA
WAKACJE NA GIEŁDZIE

SOPHARMA AD: Correction of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026

2026-06-26 19:34
publikacja
2026-06-26 19:34
Dodaj Bankier.pl w Google
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_dividend_26062026_technical_correction_EN_espi.pdf

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

203

/

2026

Date of issue:

2026-06-26

Short name of the issuer

SOPHARMA AD

Subject

Correction of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, June 26, 2026 – “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies of an error in the text of notification with out. number 194-00-162 as of June 26, 2026 on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026

The text

“The General Meeting of Shareholders approved the proposal of the Board of Directors to distribute a gross dividend to shareholders in the amount of EUR 0.052 /5.2 euro cents/ per share.”

should read

“The General Meeting of Shareholders approved the proposal of a shareholder made during the discussion under item 7 of the AGM to distribute a gross dividend to shareholders in the amount of EUR 0.052 /5.2 euro cents/ per share.”

We apologize for the inconvenience.

Annexes

File

Description

SFA_dividend_26062026_technical_correction_EN_espi.pdf

Correction of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-06-26

Ognian Donev

Executive Director

Źródło:Komunikaty spółek (ESPI)
Tematy

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki